[1]
Marushchak, A. and Shorikov, E. 2018. Pharmacoeconomic analysis of the use of ramipril and candesartan in patients with arterial hypertension. ScienceRise: Pharmaceutical Science. 3 (13) (Jun. 2018), 8–13. DOI:https://doi.org/10.15587/2519-4852.2018.135771.